Custom Linen Solutions (CLS), an Orlando-based provider of textiles and uniforms to healthcare centers, announces that they have taken on a new product line to help their ambulatory surgical center (ASC) customers.
Adequate personal protection equipment (PPE) against infections has always been a high-priority in the medical field. CLS directly addressed their concerns by incorporating a new and innovative technology called Vestex, the latest in protective medical wear.
Vestex scrubs repel blood and bodily fluids while remaining breathable, and contain an anti-microbial to prevent fabric degradation from microorganisms.
"Studies indicate that healthcare workers want barrier protection as a first line of defense against the contaminants they face every day," says Craig Mayo, president and CEO of CLS. "We are proud to help our customers address their employees number one concern so they can focus on what they do best taking care of patients."
"We applaud Custom Linen Solutions effort to equip their customers with tools for personal protection. In addition to the day-to-day PPE required in their line of work, Vestex will provide healthcare workers with additional protection against splatters from blood and bodily fluids without increasing compliance steps," says Ben Favret, president and CEO of Vestagen.
To learn more about Custom Linen Solutions rental programs for the healthcare industry, visit: www.customlinensolutions.com
To learn more about Vestex, visit: www.VestexProtects.com.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.